Your browser doesn't support javascript.
loading
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.
Ai, Jingwen; Zhang, Haocheng; Zhang, Yi; Lin, Ke; Zhang, Yanliang; Wu, Jing; Wan, Yanming; Huang, Yanfang; Song, Jieyu; Fu, Zhangfan; Wang, Hongyu; Guo, Jingxin; Jiang, Ning; Fan, Mingxiang; Zhou, Yang; Zhao, Yuanhan; Zhang, Qiran; Liu, Qiang; Lv, Jing; Li, Peiyao; Qiu, Chao; Zhang, Wenhong.
Afiliación
  • Ai J; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhang H; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhang Y; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Lin K; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhang Y; Depatment of Infectious Disease, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Jiangsu, People's Republic of China.
  • Wu J; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Wan Y; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Huang Y; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Song J; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Fu Z; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Wang H; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Guo J; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Jiang N; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Fan M; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhou Y; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhao Y; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhang Q; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Liu Q; Gobond Testing Technology (Beijing) Co., Ltd, Beijing, People's Republic of China.
  • Lv J; Gobond Testing Technology (Beijing) Co., Ltd, Beijing, People's Republic of China.
  • Li P; Gobond Testing Technology (Beijing) Co., Ltd, Beijing, People's Republic of China.
  • Qiu C; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhang W; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
Emerg Microbes Infect ; 11(1): 337-343, 2022 Dec.
Article en En | MEDLINE | ID: mdl-34935594
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos